These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9337985)

  • 21. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse relationship between central serotonergic neurotransmission and blood pressure in alcohol-dependent male subjects.
    Balldin J; Andersson M; Berggren U; Engel J; Eriksson M; Fahlke C
    J Neural Transm (Vienna); 2006 Oct; 113(10):1511-7. PubMed ID: 16465459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of serotonin in obsessive-compulsive disorder.
    Baumgarten HG; Grozdanovic Z
    Br J Psychiatry Suppl; 1998; (35):13-20. PubMed ID: 9829022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa.
    Monteleone P; Brambilla F; Bortolotti F; La Rocca A; Maj M
    Br J Psychiatry; 1998 May; 172():439-42. PubMed ID: 9747408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review.
    Newman ME; Shapira B; Lerer B
    Int J Neuropsychopharmacol; 1998 Jul; 1(1):49-69. PubMed ID: 11281946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenfluramine challenge test in obsessive-compulsive disorder--first results.
    Pidrman V; Tůma I
    Acta Medica (Hradec Kralove); 1997; 40(4):99-102. PubMed ID: 9481883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Int Clin Psychopharmacol; 1992; 7(1):45-9. PubMed ID: 1624756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased brain serotonin function in men with chronic fatigue syndrome.
    Sharpe M; Hawton K; Clements A; Cowen PJ
    BMJ; 1997 Jul; 315(7101):164-5. PubMed ID: 9251547
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.
    Quattrone A; Tedeschi G; Aguglia U; Scopacasa F; Direnzo GF; Annunziato L
    Br J Clin Pharmacol; 1983 Nov; 16(5):471-5. PubMed ID: 6639832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC; Goodman WK; Price LH
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():79-82. PubMed ID: 8201248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V; Dinan TG
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunted prolactin response to D-fenfluramine in post-stroke major depression.
    Morris P; Hopwood M; Maguire K; Norman T; Schweitzer I
    J Affect Disord; 2003 Sep; 76(1-3):273-8. PubMed ID: 12943959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients.
    Mann JJ; Malone KM; Diehl DJ; Perel J; Cooper TB; Mintun MA
    Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine responses to fenfluramine and its relationship to personality in alcoholism.
    Weijers HG; Wiesbeck GA; Jakob F; Böning J
    J Neural Transm (Vienna); 2001; 108(8-9):1093-105. PubMed ID: 11716144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine correlates of depression in abstinent heroin-dependent subjects.
    Gerra G; Zaimovic A; Zambelli U; Delsignore R; Baroni MC; Laviola G; Macchia T; Brambilla F
    Psychiatry Res; 2000 Nov; 96(3):221-34. PubMed ID: 11084218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.